Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C

Authors :: Farley, John
Gona, Philimon
Crain, Marilyn
Cervia, Joseph
Oleske, James
Seage, George
Lindsey, Jane
Source :: Journal of Acquired Immune Deficiency Syndromes (1999). April 1, 2005, Vol. 38 Issue 4, p480, 8 p.
Publication Year :: 2005
Abstract: The Pediatric AIDS Clinical Trials Group 219C (PACTG 219C) is a prospective cohort study designed to examine long-term outcomes in children born to HIV-infected women. Among the HIV-infected children, the overall prevalence of hypercholesterolemia was 13.0% and the strongest associated risk factor for hypercholesterolemia was current use of a protease inhibitor in the antiretroviral regimen.

Subjects :: HIV infection in children -- Risk factors
Cholesterol -- Risk factors
Children -- Health aspects
Hypercholesterolemia in children -- Risk factors
Hypercholesterolemia in children -- Care and treatment
Health

Tools